Skip to content
lifestyle.gopreneurs.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Insilico Medicine
Generative AI Leap: Insilico Medicine Nominates First Preclinical Candidate in the UAE
May 20, 2026
Nature Reviews Drug Discovery | Target Identification and Assessment in the Era of AI
April 29, 2026
Insilico Medicine Announces Industry’s First Longevity Board to Accelerate AI-Driven Aging Research for Drug Discovery
April 29, 2026
Insilico Medicine Announces Global R&D Collaboration with Lilly
March 29, 2026
Insilico Medicine and Tenacia Biotechnology Expand AI-Driven CNS Collaboration with Deal Value Up to US$94.75 Million
March 26, 2026
Insilico Medicine and ASKA Pharmaceutical Expand Partnership to Discover Novel Targets for Women’s Health
March 24, 2026
Insilico Medicine Launches PandaClaw: Empowering Biologists with Agentic AI for Therapeutic Discovery
March 23, 2026
Insilico Medicine to Announce 2025 Financial Results on March 30, 2026
March 13, 2026
Insilico Medicine and Qilu Pharmaceutical Reach Near $120 Million Drug Development Collaboration to Accelerate Novel Cardiometabolic Therapies
February 25, 2026
Insilico Medicine Nominates ISM5059, the Peripheral-restricted NLRP3 Inhibitor as Preclinical Candidate, for the Treatment of Multiple Inflammatory and Metabolism Indications
February 11, 2026
←
Previous Page
1
2
3
4
Next Page
→